Paul K. Wotton
2012
In 2012, Paul K. Wotton earned a total compensation of $1.6M as Former Chief Executive Officer at Antares Pharma, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $430,000 |
|---|---|
| Option Awards | $466,666 |
| Salary | $477,000 |
| Stock Awards | $259,233 |
| Other | $9,814 |
| Total | $1,642,713 |
Wotton received $477K in salary, accounting for 29% of the total pay in 2012.
Wotton also received $430K in non-equity incentive plan, $466.7K in option awards, $259.2K in stock awards and $9.8K in other compensation.
Rankings
In 2012, Paul K. Wotton's compensation ranked 4,225th out of 11,487 executives tracked by ExecPay. In other words, Wotton earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,225 out of 11,487 | 63rd |
Division Manufacturing | 1,470 out of 4,253 | 65th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 176 out of 619 | 72nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 98 out of 360 | 73rd |
Industry Surgical and Medical Instruments and Apparatus | 48 out of 215 | 78th |
Source: SEC filing on April 15, 2015.
Wotton's colleagues
We found two more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2012.